Chizurum Epeagba
Family · San Antonio, TXNPI 1275235681
Payments from drug & device makers
Across 79 payments — averaging $35.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$402
- Novo Nordisk$327
- AstraZeneca$325
- Kyowa Kirin, Inc.$241
- Lilly USA, LLC$237
- Silk Road Medical, Inc.$143
- plus $1K from 14 others
What the payments were for
- Food & beverage$2,784100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 4 | $402 |
| Novo Nordisk | 11 | $327 |
| AstraZeneca | 16 | $325 |
| Kyowa Kirin, Inc. | 2 | $241 |
| Lilly USA, LLC | 12 | $237 |
| Silk Road Medical, Inc. | 1 | $143 |
| Merck | 6 | $131 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $114 |
| Abbott | 1 | $111 |
| W. L. Gore & Associates, Inc. | 1 | $92 |
| Shield Therapeutics Inc | 5 | $89 |
| Pfizer | 4 | $86 |
| Organon | 3 | $65 |
| Astellas Pharma US Inc | 3 | $61 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $46 |
| GSK | 2 | $33 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Dynavax Technologies Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,784 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $565 |
| Cefdinir | 20 | $370 |
| Losartan Potassium | 11 | $203 |
| Gabapentin | 14 | $171 |
| Amlodipine Besylate | 11 | $162 |
| Atorvastatin Calcium | 11 | $85 |
| Azithromycin | 14 | $30 |
Paid to pharmacies, not to this prescriber.
Other family in San Antonio
- Anna CastroSan Antonio$184K
- Natalia FariasSan Antonio$124K
- Ayoade AvworoSan Antonio$111K
- Tina CoppleSan Antonio$97K
- Kim HinojosaSan Antonio$63K
- Kimberly GibergaSan Antonio$36K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.